Emma Walmsley, the CEO who led the U.K. drugmaker GSK through the Covid-19 pandemic and the transformative spinoff of its consumer-health brands, will step down at the end of the year, the company ...
Watching a weather app to see if a cold front is coming in has taken on a new meaning: The Cold and Flu Tracker app, where people can get updates on cold and flu activity at a hyperlocal level, is now ...
(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...
Hosted on MSN
GSK spin-off Haleon eyes Tylenol takeover
Haleon has lived in the shadows since it was spun off from drugs giant GlaxoSmithKline in 2022. But now the consumer healthcare firm, whose brands include Sensodyne, is on the lookout for acquisitions ...
GSK plc announces its CEO transition, with CCO Luke Miels to succeed Emma Walmsley, as shares rise 3% and the company maintains a 4% dividend yield. GSK's strengths include its HIV, vaccines, and ...
Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results